Neochem Bio Solutions Delivers Strong H1 FY27 Performance with 50% Top-Line Growth
Neochem Bio Solutions Ltd · Transcript · 03 Nov 2026, 12:06 am
Neochem Bio Solutions Delivers Strong H1 FY27 Performance with 50% Top-Line Growth Neochem reported a 50.4% YoY increase in H1 FY27 revenue from operations to Rs 68.9 Cr, with PAT rising 41.8% YoY to Rs 7.8 Cr (11.4% margin). Volume growth stood at 20% YoY, alongside an annual run-rate capacity utilization of 62%. Receivable days improved to 127 days from 161 days in Mar'26. Operating cash flows normalized significantly to negative Rs 1 Cr versus negative Rs 17 Cr in FY26. Management targets >40% CAGR over the next 5–6 years, with long-term EBITDA and PAT margin bands guided at 18%–20% and 10%–12%, respectively.
Original exchange filing (PDF)
More announcements from Neochem Bio Solutions Ltd
- Neochem Bio Solutions Limited has informed the Exchange about Link of Recording · 30 Oct 2026
- Neochem Bio Solutions Limited has informed the Exchange about Investor Presentation · 29 Oct 2026
- Neochem Bio Solutions Limited has submitted to the Exchange, the Unaudited Half Yearly financial results for the period ended September 30, 2026. · 28 Oct 2026
- Neochem Bio Solutions Limited has informed the Exchange about Schedule of meet · 27 Oct 2026
- NEOCHEM BIO SOLUTIONS LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 27 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 27 Oct 2026
- Neochem Bio Solutions has submitted Statement of Investor Grievances under Reg. 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2026. · 20 Oct 2026
- Neochem Bio Solutions Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter and half year ended on 30th September, 2026 · 20 Oct 2026
